Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Net Margin (2016 - 2025)

Abeona Therapeutics (ABEO) has 13 years of Net Margin data on record, last reported at 28416.75% in Q2 2025.

  • For Q2 2025, Net Margin changed N/A year-over-year to 28416.75%; the TTM value through Sep 2025 reached 19826.75%, changed N/A, while the annual FY2023 figure was 1548.57%, 152781.0% up from the prior year.
  • Net Margin reached 28416.75% in Q2 2025 per ABEO's latest filing, up from 475.83% in the prior quarter.
  • Across five years, Net Margin topped out at 88081.13% in Q4 2021 and bottomed at 10441.18% in Q4 2022.
  • Average Net Margin over 4 years is 11329.64%, with a median of 1013.8% recorded in 2021.
  • Peak YoY movement for Net Margin: soared 8881743bps in 2021, then crashed -9852231bps in 2022.
  • A 4-year view of Net Margin shows it stood at 88081.13% in 2021, then plummeted by -112bps to 10441.18% in 2022, then soared by 95bps to 475.83% in 2023, then soared by 6072bps to 28416.75% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 28416.75% in Q2 2025, 475.83% in Q2 2023, and 10441.18% in Q4 2022.